Bionano Genomics: Little Clinical Utility And A Whole Lot Of Burn (NASDAQ:BNGO)
seekingalpha.com
news
2022-10-18 18:07:09

Editor's note: Seeking Alpha is proud to welcome Harrier Capital as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Premium. Click here to find out more Â» cdascher/E+ via Getty Images We are short Bionano Genomics (NASDAQ:BNGO) because we contend that its product the Saphyr system has very limited utility in the clinical setting, and the basic research market is too small for the company to achieve cashflow positivity.
